Evidence map›Paper›PMID 38511180›Full record

ArticleAmerican heart journal plus : cardiology research and practice2023

Trends in incidence and clinical outcome of non-ST elevation myocardial infarction in patients with amyloidosis in the United States, 2010-2020.

John Gharbin, Adwoa Winful, Pamela Alebna, Niyati Grewal, Ahmed Brgdar, Suchelis Rhodd, Mohammed Taha, Urooj Fatima, Prafulla Mehrotra, Anekwe Onwuanyi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American heart journal plus : cardiology research and practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

John GharbinDepartment of Internal Medicine, Howard University, Washington, DC, USA.
Adwoa WinfulMedical University of South Carolina Health, Orangeburg, SC, USA.
Pamela AlebnaDivision of Cardiology, Virginia Commonwealth University, Virginia, USA.
Niyati GrewalDepartment of Internal Medicine, Howard University, Washington, DC, USA.
Ahmed BrgdarDivision of Cardiology, Howard University, Washington, DC, USA.
Suchelis RhoddDivision of Cardiology, Howard University, Washington, DC, USA.
Mohammed TahaDivision of Cardiology, Virginia Commonwealth University, Virginia, USA.
Urooj FatimaDivision of Cardiology, Howard University, Washington, DC, USA.
Prafulla MehrotraDivision of Cardiology, Howard University, Washington, DC, USA.
Anekwe OnwuanyiDivision of Cardiology, Morehouse School of Medicine, Atlanta, GA, USA.
Howard University · USVirginia Commonwealth University · USMedical University of South Carolina · USMorehouse School of Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Study objective: To assess temporal changes in clinical profile and in-hospital outcome of patients with amyloidosis presenting with non-ST elevation myocardial infarction, NSTEMI. Design/setting: We conducted a retrospective observational study using the National Inpatient Sample (NIS) database from January 1, 2010, to December 31, 2020. Main outcomes: Primary outcome of interest was trend in adjusted in-hospital mortality in patients with amyloidosis presenting with NSTEMI from 2010 to 2020. Our secondary outcomes were trend in rate of coronary revascularization, and trend in duration of hospitalization. Results: We identified 272,896 hospitalizations for amyloidosis. There was a temporal increase in incidence of NSTEMI among patients aged 18-44 years from 15.5 % to 28.0 %, a reverse trend was observed in 45-64 years: 22.1 % to 17.7 %, Conclusion: In patients with amyloidosis presenting with NSTEMI, there was increased incidence of NSTEMI among young adults, a steady trend in coronary revascularization, and a decreasing trend of adjusted all-cause in-hospital mortality and length of hospitalization from 2010 to 2020 in the United States.

Indexed as

AmyloidosisCardiac amyloidosisCoronary revascularizationNSTEMI

Identifiers

PMID38511180
PMCPMC10945973
OpenAlexW4387889763

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.